IN2009DE02299A - - Google Patents

Download PDF

Info

Publication number
IN2009DE02299A
IN2009DE02299A IN2299DE2009A IN2009DE02299A IN 2009DE02299 A IN2009DE02299 A IN 2009DE02299A IN 2299DE2009 A IN2299DE2009 A IN 2299DE2009A IN 2009DE02299 A IN2009DE02299 A IN 2009DE02299A
Authority
IN
India
Prior art keywords
pharmaceutical formulation
present
inhalation
preventing
heavy metal
Prior art date
Application number
Other languages
English (en)
Inventor
Aseem Bhatnagar
Farhan Jalees Ahmad
Neeraj Kumar
Shaheen Sultana
Gaurav Mittal
Rashid Ali
Original Assignee
Director General Defence Res & Dev Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Director General Defence Res & Dev Org filed Critical Director General Defence Res & Dev Org
Priority to IN2299DE2009 priority Critical patent/IN2009DE02299A/en
Publication of IN2009DE02299A publication Critical patent/IN2009DE02299A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2299DE2009 2009-11-09 2009-11-09 IN2009DE02299A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2299DE2009 IN2009DE02299A (https=) 2009-11-09 2009-11-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2299DE2009 IN2009DE02299A (https=) 2009-11-09 2009-11-09

Publications (1)

Publication Number Publication Date
IN2009DE02299A true IN2009DE02299A (https=) 2015-07-31

Family

ID=54396544

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2299DE2009 IN2009DE02299A (https=) 2009-11-09 2009-11-09

Country Status (1)

Country Link
IN (1) IN2009DE02299A (https=)

Similar Documents

Publication Publication Date Title
US20090298802A1 (en) Pharmaceutical Compositions
UY29905A1 (es) Formulación farmacéutica de absorción oral y su método de administración
SA99200700B1 (ar) ركاز concentrate من مادة فعالة substance active مع فورموتيرول formoterol ملائم للتخزين
NZ606548A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
JP2019517597A5 (https=)
GEP20063876B (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
ECSP14018630A (es) Formulaciones farmacéuticas novedosas
HRP20170014T1 (hr) Farmaceutski pripravak za inhalaciju
FI20002215A0 (fi) Yhdistelmäpartikkelit
TW200500098A (en) Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
MXPA05005044A (es) El uso de un agente antialergico y un esteroide para tratar rinitis alergica.
DE60216588D1 (de) Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
MX2009000849A (es) Formas de dosificacion liofilizadasdisolvibles oralmente/desintegrables que contienen particulas protegidas.
AR055363A1 (es) Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion
MX375427B (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
JP2008501655A5 (https=)
ZA200709296B (en) Ophthalmic suspension comprising an ophthalmic drug, a poloxamine and a glycolotonicity-adjusting agent, use of said composition for the manufacture of a medicament for treating ophthalmic disorders
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
IN2009DE02299A (https=)
JP2014534215A5 (https=)
CO6270213A2 (es) Composiciones farmaceuticas que comprenden acido montelukast y un unhibidor depde-4 o un corticoesteroide inhalado para administracion por inhalacion
WO2004017942A8 (en) Inhalation compositions with high drug ratios
US20230158067A1 (en) Silver nanoparticles for use in inhibiting and treating coronavirus infection